𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P2.142 A randomized, controlled trial of twice daily pramipexole in early PD

✍ Scribed by K. Kieburtz

Book ID
117753696
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
61 KB
Volume
15
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Twice-daily, low-dose pramipexole in ear
Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial
✍ Karl Kieburtz; The Parkinson Study Group PramiBID Investigators πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 1 views

## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, double‐blind, placebo controlled trial involving 311 early PD patients not receiving dopaminer

Randomized, double-blind, multicenter ev
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
✍ Robert A. Hauser; Anthony H.V. Schapira; Olivier Rascol; Paolo Barone; Yoshikuni πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 1 views

## Abstract The objective of this study was to evaluate the efficacy and safety of pramipexole extended release (ER) administered once daily in early Parkinson's disease (PD). Pramipexole immediate release (IR) administered three times daily (TID) is an efficacious and generally well‐tolerated trea